Endoscopy 2017; 49(08): 765-775
DOI: 10.1055/s-0043-105073
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Adenoma detection with blue-water infusion colonoscopy: a randomized trial

Adriane Lesne
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
2   Lyon 1 University Claude Bernard, Lyon, France
,
Olivier Rouquette
3   Hepatogastroenterology Department, University Hospital d’Estaing, Clermont-Ferrand, France
,
Sandrine Touzet
4   Hospices Civils de Lyon, pôle Information médicale Evaluation Recherche, and Université de Lyon, EA 7425 Health Services and Performance Research (HESPER), Lyon, France
,
Fabien Petit-Laurent
5   Hepatogastroenterology Department, Nord Ouest Hospital, Villefranche-sur-Saône, France
,
Gwenaelle Tourlonias
6   Hepatogastroenterology Department, University Hospital Croix Rousse, Lyon, France
,
Audrey Pasquion
7   Hepatogastroenterology Department, University Hospital Saint-Etienne, Saint-Priest en Jarez, France
8   Hepatogastroenterology Department, St Joseph St Luc Hospital, Lyon, France
,
Jérôme Rivory
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
6   Hepatogastroenterology Department, University Hospital Croix Rousse, Lyon, France
,
Guillermo Aguero Garcete
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
,
Julien Scanzi
3   Hepatogastroenterology Department, University Hospital d’Estaing, Clermont-Ferrand, France
,
Sylvaine Chalumeau
5   Hepatogastroenterology Department, Nord Ouest Hospital, Villefranche-sur-Saône, France
,
Christine Chambon-Augoyard
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
,
Driffa Moussata
9   Hepatogastroenterology Department, University Hospital Lyon Sud, Pierre-Bénite, France
,
Florence Leger-Nguyen
5   Hepatogastroenterology Department, Nord Ouest Hospital, Villefranche-sur-Saône, France
,
Stéphane Degeorges
10   Hepatogastroenterology Department, Public Hospital Bourgoin-Jallieu, France
,
Marion Chauvenet
9   Hepatogastroenterology Department, University Hospital Lyon Sud, Pierre-Bénite, France
,
Thierry Fontanges
10   Hepatogastroenterology Department, Public Hospital Bourgoin-Jallieu, France
,
Sandrine Baubet
6   Hepatogastroenterology Department, University Hospital Croix Rousse, Lyon, France
,
Philippe Brulet
10   Hepatogastroenterology Department, Public Hospital Bourgoin-Jallieu, France
,
Claire Billioud
6   Hepatogastroenterology Department, University Hospital Croix Rousse, Lyon, France
,
Elsa Thimonier
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
,
Karine Stroeymeyt-Martin
9   Hepatogastroenterology Department, University Hospital Lyon Sud, Pierre-Bénite, France
,
Benjamin Hamel
5   Hepatogastroenterology Department, Nord Ouest Hospital, Villefranche-sur-Saône, France
,
Emmanuelle Graillot
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
,
Claire Cruiziat
10   Hepatogastroenterology Department, Public Hospital Bourgoin-Jallieu, France
,
Olivia Scalone
5   Hepatogastroenterology Department, Nord Ouest Hospital, Villefranche-sur-Saône, France
,
Marc O’Brien
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
,
Denis Péré-Vergé
8   Hepatogastroenterology Department, St Joseph St Luc Hospital, Lyon, France
,
Jean-Christophe Souquet
6   Hepatogastroenterology Department, University Hospital Croix Rousse, Lyon, France
,
Jean-Marc Phelip
7   Hepatogastroenterology Department, University Hospital Saint-Etienne, Saint-Priest en Jarez, France
,
Laurent Poincloux
3   Hepatogastroenterology Department, University Hospital d’Estaing, Clermont-Ferrand, France
,
Stéphanie Poupon-Bourdy
4   Hospices Civils de Lyon, pôle Information médicale Evaluation Recherche, and Université de Lyon, EA 7425 Health Services and Performance Research (HESPER), Lyon, France
,
Angélique Denis
4   Hospices Civils de Lyon, pôle Information médicale Evaluation Recherche, and Université de Lyon, EA 7425 Health Services and Performance Research (HESPER), Lyon, France
,
Laurent Magaud
4   Hospices Civils de Lyon, pôle Information médicale Evaluation Recherche, and Université de Lyon, EA 7425 Health Services and Performance Research (HESPER), Lyon, France
,
Thierry Ponchon
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
2   Lyon 1 University Claude Bernard, Lyon, France
11   INSERM U1032, LabTau, Lyon, France
,
Mathieu Pioche
1   Hepatogastroenterology Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, France
2   Lyon 1 University Claude Bernard, Lyon, France
11   INSERM U1032, LabTau, Lyon, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 05. Mai 2016

accepted after revision 15. Februar 2017

Publikationsdatum:
11. April 2017 (online)

Preview

Abstract

Background and aims Colonoscopy is currently the reference method to detect colorectal neoplasia, yet some adenomas remain undetected. The water infusion technique and dying with indigo carmine has shown interesting results for reducing this miss rate. The aim of this study was to compare the adenoma detection rate (adenoma and adenocarcinoma; ADR) and the mean number of adenomas per patient (MAP) for blue-water infusion colonoscopy (BWIC) versus standard colonoscopy.

Methods We performed a multicenter, randomized controlled trial in eight units, including patients with a validated indication for colonoscopy (symptoms, familial or personal history, fecal occult blood test positive). Consenting patients were randomized 1:1 to BWIC or standard colonoscopy. All colonoscopies were performed by experienced colonoscopists. All colonoscopy quality indicators were prospectively recorded.

Results Among the 1065 patients included, colonoscopies were performed completely for 983 patients (514 men; mean age 59.1). The ADR was not significantly different between the groups; 40.4 % in the BWIC group versus 37.5 % in the standard colonoscopy group (odds ratio [OR] 1.13; 95 % confidence interval [CI] 0.87 – 1.48; P = 0.35). MAP was significantly greater in the BWIC group (0.79) than in the standard colonoscopy group (0.64; P = 0.005). For advanced adenomas, the results were 50 (10.2 %) and 36 (7.3 %), respectively (P = 0.10). The cecal intubation rate was not different but the time to cecal intubation was significantly longer in BWIC group (9.9 versus 6.2 minutes; P < 0.001).

Conclusion Despite the higher MAP with BWIC, the routine use of BWIC does not translate to a higher ADR. Whether increased detection ultimately results in a lower rate of interval carcinoma is not yet known.

Clinical trials registration: EudraCT 2012-A00548 – 35; NCT01937429.